We are live on ! Find out more
CTSO icon

Cytosorbents Corp

51 hedge funds and large institutions have $14.1M invested in Cytosorbents Corp in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

2.34% less ownership

Funds ownership: 30.3%27.96% (-2.3%)

4% less funds holding

Funds holding: 5351 (-2)

43% less capital invested

Capital invested by funds: $24.7M → $14.1M (-$10.6M)

Holders
51
Holders Change
-2
Holders Change %
-3.77%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
14
Reduced
10
Closed
12
Calls
$15K
Puts
Net Calls
+$15K
Net Calls Change
-$8K

CTSO Hedge Fund Activity: Q4 2024 in Review

51 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2024, worth a combined $14.1M — down 43% from $24.7M a quarter earlier.

Fund positioning in CTSO was balanced in Q4 2024: 12 funds opened new positions, 12 closed out, 14 added to existing stakes and 10 trimmed.

The largest buyer was UBS Group, adding an estimated $140K. The largest seller was Granahan Investment Management, cutting an estimated $874K.

  • 51 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2024, down from 53 in Q3 2024.
  • Funds reported $14.1M of Cytosorbents Corp stock for Q4 2024, down 43% quarter-over-quarter.
  • 12 funds opened new Cytosorbents Corp positions in Q4 2024 and 12 closed out, a net change of 0 holders.
  • The largest Cytosorbents Corp buyer in Q4 2024 was UBS Group, an estimated $140K added.
  • The largest Cytosorbents Corp seller in Q4 2024 was Granahan Investment Management, an estimated $874K sold.

Based on aggregated 13F filings for Q4 2024.